Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 3 | 2019 | 98 | 1.360 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2012 | 16 | 1.180 |
Why?
|
Macaca mulatta | 7 | 2019 | 332 | 1.120 |
Why?
|
Homeodomain Proteins | 4 | 2012 | 51 | 1.090 |
Why?
|
Whole-Body Irradiation | 4 | 2019 | 50 | 1.070 |
Why?
|
Immunoglobulin Class Switching | 3 | 2013 | 5 | 0.970 |
Why?
|
B-Lymphocytes | 4 | 2013 | 74 | 0.960 |
Why?
|
Macaca fascicularis | 4 | 2019 | 401 | 0.940 |
Why?
|
Animals | 40 | 2020 | 7694 | 0.940 |
Why?
|
T-Lymphocytes | 6 | 2019 | 128 | 0.830 |
Why?
|
Mice | 22 | 2020 | 2524 | 0.710 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2018 | 9 | 0.640 |
Why?
|
Transcription, Genetic | 1 | 2019 | 143 | 0.640 |
Why?
|
Energy Metabolism | 1 | 2019 | 147 | 0.630 |
Why?
|
Endometrium | 1 | 2019 | 175 | 0.620 |
Why?
|
Blood Platelets | 4 | 2020 | 41 | 0.610 |
Why?
|
Mitochondria | 1 | 2019 | 188 | 0.610 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2017 | 44 | 0.600 |
Why?
|
Iron | 1 | 2018 | 117 | 0.590 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2015 | 148 | 0.560 |
Why?
|
Platelet Aggregation | 2 | 2020 | 22 | 0.550 |
Why?
|
Nuclear Pore Complex Proteins | 2 | 2012 | 6 | 0.540 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2012 | 17 | 0.540 |
Why?
|
Transcription Factors | 2 | 2015 | 181 | 0.510 |
Why?
|
Citric Acid | 1 | 2014 | 6 | 0.510 |
Why?
|
Hirudins | 1 | 2014 | 19 | 0.500 |
Why?
|
Heparin | 1 | 2014 | 76 | 0.480 |
Why?
|
Fibrinolytic Agents | 1 | 2014 | 72 | 0.480 |
Why?
|
Antibody Formation | 2 | 2019 | 51 | 0.450 |
Why?
|
Antibody Diversity | 1 | 2013 | 1 | 0.440 |
Why?
|
H-2 Antigens | 1 | 2013 | 7 | 0.440 |
Why?
|
Gene Fusion | 1 | 2012 | 2 | 0.440 |
Why?
|
Translocation, Genetic | 1 | 2012 | 21 | 0.430 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 24 | 0.430 |
Why?
|
DNA Repair | 1 | 2012 | 64 | 0.410 |
Why?
|
Repressor Proteins | 3 | 2015 | 52 | 0.410 |
Why?
|
Leukemia | 2 | 2012 | 40 | 0.400 |
Why?
|
Histone Deacetylases | 3 | 2015 | 8 | 0.390 |
Why?
|
Hydroxamic Acids | 3 | 2015 | 21 | 0.370 |
Why?
|
Nitrites | 3 | 2020 | 21 | 0.370 |
Why?
|
Leukemia, Experimental | 1 | 2009 | 3 | 0.360 |
Why?
|
Mutagenesis, Insertional | 1 | 2009 | 15 | 0.350 |
Why?
|
Retroviridae | 1 | 2009 | 29 | 0.350 |
Why?
|
Mice, Transgenic | 6 | 2017 | 261 | 0.340 |
Why?
|
Mesangial Cells | 3 | 2013 | 10 | 0.340 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2012 | 24 | 0.330 |
Why?
|
Radiation Injuries, Experimental | 3 | 2019 | 34 | 0.330 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 264 | 0.320 |
Why?
|
Gamma Rays | 2 | 2019 | 25 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 58 | 0.300 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2017 | 21 | 0.300 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 105 | 0.290 |
Why?
|
Pre-Eclampsia | 2 | 2019 | 69 | 0.280 |
Why?
|
Species Specificity | 2 | 2019 | 90 | 0.280 |
Why?
|
Female | 18 | 2019 | 20126 | 0.280 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 43 | 0.270 |
Why?
|
MicroRNAs | 3 | 2013 | 180 | 0.270 |
Why?
|
Aging | 1 | 2012 | 953 | 0.260 |
Why?
|
Cell Proliferation | 5 | 2019 | 602 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 95 | 0.260 |
Why?
|
Disease Models, Animal | 9 | 2020 | 1040 | 0.250 |
Why?
|
Lameness, Animal | 1 | 2004 | 1 | 0.240 |
Why?
|
Carnivora | 1 | 2004 | 2 | 0.240 |
Why?
|
Enzyme Inhibitors | 3 | 2015 | 176 | 0.240 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2004 | 3 | 0.240 |
Why?
|
Spinal Cord Compression | 1 | 2004 | 7 | 0.240 |
Why?
|
Dose-Response Relationship, Radiation | 3 | 2019 | 78 | 0.240 |
Why?
|
Mice, Inbred C57BL | 7 | 2017 | 773 | 0.240 |
Why?
|
Fluorodeoxyuridylate | 2 | 2016 | 23 | 0.240 |
Why?
|
Interleukin-6 | 3 | 2013 | 248 | 0.230 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 611 | 0.230 |
Why?
|
Decompression, Surgical | 1 | 2004 | 54 | 0.230 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 67 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2014 | 200 | 0.210 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 326 | 0.210 |
Why?
|
Flow Cytometry | 2 | 2013 | 187 | 0.210 |
Why?
|
Humans | 21 | 2020 | 32297 | 0.200 |
Why?
|
Nitric Oxide Donors | 1 | 2020 | 8 | 0.190 |
Why?
|
Klebsiella Infections | 1 | 2020 | 4 | 0.190 |
Why?
|
Blood Coagulation | 1 | 2020 | 15 | 0.190 |
Why?
|
Nitric Oxide | 3 | 2020 | 121 | 0.190 |
Why?
|
Bone Marrow Cells | 2 | 2018 | 119 | 0.180 |
Why?
|
Oxidative Stress | 2 | 2019 | 230 | 0.180 |
Why?
|
Calcium | 2 | 2019 | 310 | 0.180 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2019 | 8 | 0.170 |
Why?
|
Platelet Activation | 2 | 2020 | 13 | 0.170 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 6 | 0.170 |
Why?
|
Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 502 | 0.170 |
Why?
|
Hematopoietic System | 1 | 2019 | 3 | 0.170 |
Why?
|
Calcium Channels, T-Type | 1 | 2019 | 29 | 0.170 |
Why?
|
Primates | 1 | 2019 | 111 | 0.170 |
Why?
|
Immunity | 1 | 2019 | 22 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 61 | 0.160 |
Why?
|
Immunophenotyping | 2 | 2009 | 51 | 0.160 |
Why?
|
Mutation | 2 | 2012 | 503 | 0.160 |
Why?
|
Spleen | 3 | 2015 | 87 | 0.160 |
Why?
|
Hemodynamics | 1 | 2019 | 155 | 0.160 |
Why?
|
Peptide Hormones | 1 | 2018 | 11 | 0.160 |
Why?
|
Fibronectins | 1 | 2018 | 36 | 0.160 |
Why?
|
RNA, Messenger | 4 | 2015 | 534 | 0.160 |
Why?
|
Menstrual Cycle | 1 | 2018 | 59 | 0.160 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2018 | 62 | 0.160 |
Why?
|
Anemia | 1 | 2018 | 60 | 0.150 |
Why?
|
Bone Marrow | 1 | 2018 | 71 | 0.150 |
Why?
|
RNA, Small Interfering | 3 | 2019 | 117 | 0.150 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 101 | 0.150 |
Why?
|
Glycerophosphates | 1 | 2017 | 4 | 0.150 |
Why?
|
Brain Injuries | 1 | 2018 | 91 | 0.150 |
Why?
|
Liver Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 154 | 0.150 |
Why?
|
Abdominal Wall | 1 | 2017 | 22 | 0.150 |
Why?
|
Deoxycytidine | 1 | 2017 | 68 | 0.150 |
Why?
|
Anemia, Sickle Cell | 1 | 2017 | 43 | 0.140 |
Why?
|
Lupus Nephritis | 1 | 2017 | 30 | 0.140 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 84 | 0.140 |
Why?
|
Area Under Curve | 2 | 2014 | 95 | 0.140 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 10 | 0.140 |
Why?
|
Ethylenediamines | 1 | 2016 | 6 | 0.140 |
Why?
|
Extracellular Matrix | 1 | 2018 | 245 | 0.140 |
Why?
|
Chelating Agents | 1 | 2016 | 17 | 0.140 |
Why?
|
Apoptosis | 5 | 2017 | 368 | 0.130 |
Why?
|
Cell Cycle | 2 | 2013 | 78 | 0.130 |
Why?
|
Zinc | 1 | 2016 | 32 | 0.130 |
Why?
|
Gene Expression | 2 | 2018 | 345 | 0.130 |
Why?
|
Lipopolysaccharides | 2 | 2013 | 110 | 0.130 |
Why?
|
Chorionic Villi | 1 | 2015 | 7 | 0.130 |
Why?
|
Immunoglobulin G | 2 | 2014 | 121 | 0.130 |
Why?
|
Macrophages | 2 | 2015 | 194 | 0.130 |
Why?
|
Pyrimidines | 1 | 2015 | 65 | 0.130 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 101 | 0.130 |
Why?
|
Platelet Function Tests | 1 | 2014 | 6 | 0.130 |
Why?
|
Myocardium | 1 | 2016 | 196 | 0.130 |
Why?
|
Down-Regulation | 1 | 2015 | 144 | 0.130 |
Why?
|
Heart | 1 | 2016 | 182 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 45 | 0.120 |
Why?
|
Hemoglobins | 1 | 2014 | 49 | 0.120 |
Why?
|
Phosphoproteins | 1 | 2015 | 55 | 0.120 |
Why?
|
Erythrocytes | 1 | 2014 | 45 | 0.120 |
Why?
|
E2F2 Transcription Factor | 1 | 2013 | 1 | 0.120 |
Why?
|
Cells, Cultured | 2 | 2013 | 846 | 0.120 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 268 | 0.120 |
Why?
|
Anticoagulants | 1 | 2014 | 127 | 0.110 |
Why?
|
Signal Transduction | 3 | 2014 | 701 | 0.110 |
Why?
|
Collagen | 1 | 2014 | 228 | 0.110 |
Why?
|
NF-kappa B | 1 | 2013 | 82 | 0.110 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 600 | 0.110 |
Why?
|
Neoplasms | 2 | 2019 | 695 | 0.110 |
Why?
|
Cell Line | 4 | 2019 | 462 | 0.110 |
Why?
|
Blotting, Western | 2 | 2013 | 305 | 0.110 |
Why?
|
Interleukin-4 | 1 | 2013 | 22 | 0.110 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 47 | 0.110 |
Why?
|
Lymphopoiesis | 1 | 2012 | 4 | 0.110 |
Why?
|
Lymphopenia | 1 | 2012 | 12 | 0.110 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2012 | 9 | 0.100 |
Why?
|
Thymidylate Synthase | 1 | 2012 | 14 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 56 | 0.100 |
Why?
|
Mice, Inbred NZB | 3 | 2017 | 4 | 0.100 |
Why?
|
Phalaris | 1 | 2010 | 1 | 0.090 |
Why?
|
Cattle Diseases | 1 | 2010 | 3 | 0.090 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 492 | 0.090 |
Why?
|
Haemonchiasis | 1 | 2010 | 1 | 0.090 |
Why?
|
Haemonchus | 1 | 2010 | 1 | 0.090 |
Why?
|
Sheep Diseases | 1 | 2010 | 3 | 0.090 |
Why?
|
Plant Oils | 1 | 2010 | 16 | 0.090 |
Why?
|
Leukemia, B-Cell | 1 | 2009 | 5 | 0.090 |
Why?
|
Blotting, Southern | 1 | 2009 | 24 | 0.090 |
Why?
|
ras Proteins | 1 | 2009 | 10 | 0.090 |
Why?
|
Male | 6 | 2019 | 19488 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2014 | 468 | 0.090 |
Why?
|
Kidney | 1 | 2014 | 529 | 0.090 |
Why?
|
Platelet Adhesiveness | 2 | 2020 | 14 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2015 | 759 | 0.080 |
Why?
|
U937 Cells | 1 | 2007 | 8 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2019 | 3358 | 0.070 |
Why?
|
Base Sequence | 1 | 2007 | 257 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 287 | 0.070 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 359 | 0.070 |
Why?
|
Acute Disease | 1 | 2007 | 255 | 0.070 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 77 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 119 | 0.070 |
Why?
|
Aqueous Humor | 1 | 2005 | 3 | 0.070 |
Why?
|
Acetylation | 2 | 2017 | 16 | 0.070 |
Why?
|
Horses | 1 | 2005 | 14 | 0.070 |
Why?
|
Vitreous Body | 1 | 2005 | 10 | 0.070 |
Why?
|
Doxycycline | 1 | 2005 | 25 | 0.070 |
Why?
|
DNA Damage | 2 | 2017 | 100 | 0.070 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2005 | 1 | 0.070 |
Why?
|
HTLV-I Infections | 1 | 2005 | 1 | 0.070 |
Why?
|
Proviruses | 1 | 2005 | 3 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 105 | 0.060 |
Why?
|
Viral Load | 1 | 2005 | 70 | 0.060 |
Why?
|
Ataxia | 1 | 2004 | 6 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 167 | 0.060 |
Why?
|
Mice, Inbred MRL lpr | 2 | 2015 | 3 | 0.060 |
Why?
|
Pregnancy | 2 | 2019 | 1010 | 0.060 |
Why?
|
Organ Specificity | 2 | 2019 | 81 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 736 | 0.060 |
Why?
|
Antibodies, Antinuclear | 2 | 2014 | 18 | 0.060 |
Why?
|
Body Weight | 2 | 2016 | 311 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 309 | 0.050 |
Why?
|
Light | 1 | 2020 | 26 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2020 | 9 | 0.050 |
Why?
|
Rats, Transgenic | 1 | 2019 | 52 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2019 | 49 | 0.040 |
Why?
|
Radiometry | 1 | 2019 | 39 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 7 | 0.040 |
Why?
|
Thymus Gland | 1 | 2019 | 16 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2019 | 28 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 920 | 0.040 |
Why?
|
Adult | 3 | 2019 | 9467 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2019 | 33 | 0.040 |
Why?
|
Angiotensinogen | 1 | 2019 | 73 | 0.040 |
Why?
|
Immunotherapy | 1 | 2019 | 83 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2019 | 106 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 4 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2017 | 32 | 0.040 |
Why?
|
Tumor Burden | 1 | 2017 | 61 | 0.040 |
Why?
|
Cytarabine | 1 | 2017 | 55 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2017 | 75 | 0.040 |
Why?
|
Tubulin | 1 | 2017 | 12 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 58 | 0.040 |
Why?
|
Isoenzymes | 1 | 2017 | 62 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 57 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 756 | 0.040 |
Why?
|
Doxorubicin | 1 | 2017 | 79 | 0.040 |
Why?
|
Random Allocation | 1 | 2017 | 220 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 222 | 0.040 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2016 | 7 | 0.030 |
Why?
|
Aptamers, Nucleotide | 1 | 2016 | 10 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2016 | 25 | 0.030 |
Why?
|
Liposomes | 1 | 2016 | 27 | 0.030 |
Why?
|
Cell Death | 1 | 2016 | 77 | 0.030 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2015 | 5 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 94 | 0.030 |
Why?
|
Protein Precursors | 1 | 2015 | 22 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 18 | 0.030 |
Why?
|
Prostate | 1 | 2016 | 74 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2015 | 135 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2015 | 58 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 41 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2015 | 31 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2015 | 11 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 68 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 22 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 675 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 69 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 78 | 0.030 |
Why?
|
Nitrite Reductases | 1 | 2014 | 3 | 0.030 |
Why?
|
Carbonic Anhydrases | 1 | 2014 | 4 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 15 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2015 | 30 | 0.030 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2014 | 10 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 12 | 0.030 |
Why?
|
Ribonucleotide Reductases | 1 | 2014 | 6 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 196 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
Rats | 1 | 2019 | 1675 | 0.030 |
Why?
|
Lipids | 1 | 2016 | 226 | 0.030 |
Why?
|
Antigens, CD | 1 | 2015 | 105 | 0.030 |
Why?
|
Thiophenes | 1 | 2014 | 24 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 65 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 152 | 0.030 |
Why?
|
Sulfonamides | 1 | 2014 | 67 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 79 | 0.030 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2015 | 146 | 0.030 |
Why?
|
Phenotype | 1 | 2016 | 656 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2014 | 30 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 100 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 171 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2013 | 10 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 26 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 21 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 27 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2013 | 34 | 0.030 |
Why?
|
Tristetraprolin | 1 | 2013 | 2 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 263 | 0.030 |
Why?
|
Protein Transport | 1 | 2013 | 75 | 0.030 |
Why?
|
Proteinuria | 1 | 2014 | 61 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 25 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 462 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2013 | 63 | 0.030 |
Why?
|
Phosphorylation | 1 | 2013 | 234 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 279 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 213 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 410 | 0.030 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 18 | 0.030 |
Why?
|
Benzoquinones | 1 | 2012 | 5 | 0.030 |
Why?
|
Disease Progression | 1 | 2015 | 618 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 3 | 0.030 |
Why?
|
DNA | 1 | 2014 | 229 | 0.030 |
Why?
|
Interleukin-12 | 1 | 2012 | 30 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 23 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 94 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2012 | 90 | 0.030 |
Why?
|
Genetic Loci | 1 | 2012 | 149 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 171 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 90 | 0.030 |
Why?
|
Electrocardiography | 1 | 2016 | 635 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 149 | 0.020 |
Why?
|
Brain | 1 | 2018 | 971 | 0.020 |
Why?
|
Foodborne Diseases | 1 | 2010 | 2 | 0.020 |
Why?
|
Pons | 1 | 2010 | 7 | 0.020 |
Why?
|
West Virginia | 1 | 2010 | 15 | 0.020 |
Why?
|
Time Factors | 1 | 2016 | 2181 | 0.020 |
Why?
|
Paresis | 1 | 2010 | 11 | 0.020 |
Why?
|
Brain Stem | 1 | 2010 | 21 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 49 | 0.020 |
Why?
|
Cattle | 1 | 2010 | 101 | 0.020 |
Why?
|
Parasite Egg Count | 1 | 2010 | 1 | 0.020 |
Why?
|
Gerbillinae | 1 | 2010 | 2 | 0.020 |
Why?
|
Hindlimb | 1 | 2010 | 54 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 163 | 0.020 |
Why?
|
Feces | 1 | 2010 | 36 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 133 | 0.020 |
Why?
|
Sheep | 1 | 2010 | 233 | 0.020 |
Why?
|
Spinal Cord | 1 | 2010 | 139 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 2626 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 413 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2014 | 4050 | 0.020 |
Why?
|
Horse Diseases | 1 | 2005 | 1 | 0.020 |
Why?
|
Uveitis | 1 | 2005 | 2 | 0.020 |
Why?
|
Biological Availability | 1 | 2005 | 22 | 0.020 |
Why?
|
DNA, Viral | 1 | 2005 | 52 | 0.020 |
Why?
|
Administration, Oral | 1 | 2005 | 185 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 190 | 0.020 |
Why?
|
Rabbits | 1 | 2005 | 199 | 0.020 |
Why?
|
Aged | 1 | 2014 | 10398 | 0.010 |
Why?
|
Middle Aged | 1 | 2014 | 11949 | 0.010 |
Why?
|